4D Molecular Therapeutics, Inc. revenue breakdown overview

4D Molecular Therapeutics, Inc. revenue for the last year amounted to 20.72 M USD, the most of which — 20.72 M USD — came from its highest performing source at the moment, Gene Therapeutic Products, the year earlier bringing 3.13 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought 4D Molecular Therapeutics, Inc. 20.16 M USD, and the year before that — 35.00 k USD.